Abstract
A pilot study (NCT:01851447) was conducted to identify predictive biomarkers of decreasing barrier function of skeletal muscle membranes associated with the pathophysiology and clinical severity of fragile sarcolemmal muscular dystrophies. Membrane barrier function was evaluated over five days using plasma alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatine kinase (CK), and lactate dehydrogenase (LDH) levels, before and after routine morning activities and motor function testing in eleven ambulatory subjects with limb-girdle muscular dystrophy (LGMD).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
